LJPC-401 is La Jolla
's novel formulation of hepcidin, a naturally occurring peptide hormone that is the body's regulator of iron absorption and distribution.
This year Conner is continuing her decades-long commitment to civic and cultural organizations in San Diego, with her support of The San Diego Zoological Society, San Diego Museum of Art, San Diego Hospice, San Diego YMCA, La Jolla
Playhouse, La Jolla
Library, The Scripps Research Institute, The Doris Howell Foundation, La Jolla
Literary Society, The Charitable Foundation, Hospice, Friends of the Library, Sunrise Rotary, Clarity Foundation, Borrego Art Institute and The Athenaeum.
is developing LJPC-401 for the treatment of iron overload, which occurs as a result of diseases such as hereditary hemochromatosis (HH) and beta thalassemia.
“It's a pleasure to recognize our agents and staff for their remarkable consistency in the La Jolla
market and continued leadership in the national real estate arena,” said David M.
GIAPREZA is marketed by La Jolla
Pharmaceutical Company on behalf of La Jolla
Pharma, LLC, its wholly owned subsidiary.
"We are excited to welcome Darryl to La Jolla
's leadership team," said George Tidmarsh, M.D., Ph.D., La Jolla
's president and chief executive officer.
Pharmaceutical Company (Nasdaq: LJPC) has filed for European approval of GIAPREZA (angiotensin II) Injection for Intravenous Infusion, the company said on Monday.
A premier Pacific Ocean-front property designed in the 1960s by famed modernist Ladd & Kelsey, Muse La Jolla
has been meticulously restored and converted into 16 multimillion-dollar units for international home collectors.
The Marine Room, opened in 1941, is known for being on the finest beach in La Jolla
, a section of San Diego that has been made more famous by the Netflix hit Grace and Frankie.
, CA, May 16, 2017 --(PR.com)-- "My ongoing body of work involves the visual interpretation of cliches, euphemisms and idioms." -Robert Deyber
(OTCQB: SOAN) has forged a joint venture with La Jolla
Capital Partners LLC focused on the funding and management of US Food and Drug Administration Liprostin Phase III trials, as well as the licensing of Liprostin worldwide thereafter, the company said.